When a nerve impulse arrives at a 5-HT or noradrenaline nerve terminal the neurotransmitter is released from the synaptic vesicle into the synaptic cleft. Neurotransmitter molecules bind to their specific receptors on the post-synaptic membrane and the nerve impulse is propagated or inhibited, depending on the receptor type. 5-HT and noradrenaline molecules are then released from their receptors and taken back into the nerve terminal via either the 5-HT or noradrenaline re-uptake transporters. 5-HT and noradrenaline are degraded by monoamine oxidase (MAO) and catechol-O-methyltransferase (COMT), these enzymes are found in the nerve terminal.1,2
Click here: Learn about the normal processes of serotonin and noradrenaline synaptic activity
Related content
People with BD can experience residual symptoms that impact on functioning and QoL – these symptoms can benefit from an integrated approach to treatment
Patients with bipolar disorder and comorbidities are typically more complex cases than those without medical or psychiatric comorbidities
Bipolar disorder (BD) includes several disorders of emotion, thought, and energy, characterized by biphasic mood episodes of mania or hypomania and depression.